LPL Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.02M | Sell |
36,798
-27,378
| -43% | -$1.5M | ﹤0.01% | 3089 |
|
2025
Q1 | $4.54M | Buy |
64,176
+32,903
| +105% | +$2.33M | ﹤0.01% | 2227 |
|
2024
Q4 | $2.06M | Sell |
31,273
-1,701
| -5% | -$112K | ﹤0.01% | 2822 |
|
2024
Q3 | $2.32M | Buy |
32,974
+1,541
| +5% | +$108K | ﹤0.01% | 2558 |
|
2024
Q2 | $2.59M | Sell |
31,433
-1,049
| -3% | -$86.4K | ﹤0.01% | 2365 |
|
2024
Q1 | $2.84M | Buy |
32,482
+1,258
| +4% | +$110K | ﹤0.01% | 2218 |
|
2023
Q4 | $3.01M | Buy |
31,224
+432
| +1% | +$41.7K | ﹤0.01% | 2065 |
|
2023
Q3 | $2.72M | Buy |
30,792
+3,982
| +15% | +$352K | ﹤0.01% | 2044 |
|
2023
Q2 | $2.32M | Buy |
26,810
+1,412
| +6% | +$122K | ﹤0.01% | 2109 |
|
2023
Q1 | $2.47M | Sell |
25,398
-289
| -1% | -$28.1K | ﹤0.01% | 1973 |
|
2022
Q4 | $2.66M | Sell |
25,687
-859
| -3% | -$88.9K | ﹤0.01% | 1860 |
|
2022
Q3 | $2.25M | Sell |
26,546
-3,163
| -11% | -$268K | ﹤0.01% | 1883 |
|
2022
Q2 | $2.46M | Sell |
29,709
-2,280
| -7% | -$189K | ﹤0.01% | 1870 |
|
2022
Q1 | $2.47M | Sell |
31,989
-34,492
| -52% | -$2.66M | ﹤0.01% | 1887 |
|
2021
Q4 | $5.88M | Sell |
66,481
-5,610
| -8% | -$496K | ﹤0.01% | 1354 |
|
2021
Q3 | $5.57M | Buy |
72,091
+7,424
| +11% | +$574K | 0.01% | 1324 |
|
2021
Q2 | $5.4M | Sell |
64,667
-8,082
| -11% | -$674K | 0.01% | 1289 |
|
2021
Q1 | $5.49M | Buy |
72,749
+6,731
| +10% | +$508K | 0.01% | 1164 |
|
2020
Q4 | $5.79M | Buy |
66,018
+17,994
| +37% | +$1.58M | 0.01% | 1036 |
|
2020
Q3 | $3.65M | Buy |
48,024
+136
| +0.3% | +$10.3K | 0.01% | 1112 |
|
2020
Q2 | $5.91M | Buy |
47,888
+4,045
| +9% | +$499K | 0.01% | 795 |
|
2020
Q1 | $3.71M | Buy |
43,843
+5,059
| +13% | +$428K | 0.01% | 874 |
|
2019
Q4 | $3.28M | Sell |
38,784
-1,322
| -3% | -$112K | 0.01% | 1054 |
|
2019
Q3 | $2.7M | Sell |
40,106
-2,851
| -7% | -$192K | 0.01% | 1079 |
|
2019
Q2 | $3.68M | Buy |
42,957
+8,547
| +25% | +$731K | 0.01% | 916 |
|
2019
Q1 | $3.06M | Buy |
34,410
+4,404
| +15% | +$391K | 0.01% | 958 |
|
2018
Q4 | $2.56M | Buy |
30,006
+1,263
| +4% | +$108K | 0.01% | 952 |
|
2018
Q3 | $2.79M | Sell |
28,743
-781
| -3% | -$75.7K | 0.01% | 980 |
|
2018
Q2 | $2.78M | Buy |
29,524
+19,790
| +203% | +$1.86M | 0.01% | 952 |
|
2018
Q1 | $789K | Sell |
9,734
-2,624
| -21% | -$213K | ﹤0.01% | 1771 |
|
2017
Q4 | $1.1M | Sell |
12,358
-1,393
| -10% | -$124K | ﹤0.01% | 1447 |
|
2017
Q3 | $1.27M | Buy |
13,751
+203
| +1% | +$18.8K | ﹤0.01% | 1263 |
|
2017
Q2 | $1.22M | Buy |
13,548
+10,216
| +307% | +$922K | ﹤0.01% | 1245 |
|
2017
Q1 | $291K | Buy |
3,332
+750
| +29% | +$65.5K | ﹤0.01% | 2223 |
|
2016
Q4 | $218K | Buy |
+2,582
| New | +$218K | ﹤0.01% | 2421 |
|
2016
Q2 | – | Sell |
-6,244
| Closed | -$518K | – | 2654 |
|
2016
Q1 | $518K | Sell |
6,244
-2,457
| -28% | -$204K | ﹤0.01% | 2134 |
|
2015
Q4 | $901K | Buy |
8,701
+2,851
| +49% | +$295K | ﹤0.01% | 1762 |
|
2015
Q3 | $641K | Buy |
5,850
+649
| +12% | +$71.1K | ﹤0.01% | 1573 |
|
2015
Q2 | $727K | Buy |
5,201
+1,275
| +32% | +$178K | ﹤0.01% | 1598 |
|
2015
Q1 | $475K | Buy |
3,926
+1,561
| +66% | +$189K | ﹤0.01% | 1885 |
|
2014
Q4 | $214K | Sell |
2,365
-1,438
| -38% | -$130K | ﹤0.01% | 2455 |
|
2014
Q3 | $268K | Sell |
3,803
-8,631
| -69% | -$608K | ﹤0.01% | 2259 |
|
2014
Q2 | $774K | Sell |
12,434
-3,284
| -21% | -$204K | ﹤0.01% | 1505 |
|
2014
Q1 | $1.07M | Buy |
15,718
+3,327
| +27% | +$227K | 0.01% | 1222 |
|
2013
Q4 | $872K | Buy |
12,391
+5,438
| +78% | +$383K | 0.01% | 1329 |
|
2013
Q3 | $473K | Buy |
+6,953
| New | +$473K | ﹤0.01% | 1695 |
|